Deccan Health Care (DECCAN.BO) Stock Analysis & Winston Score
Deccan Health Care Ltd is an Indian pharmaceutical company that makes and sells a range of healthcare products, including nutritional supplements, vitamins, and specialty medicines. Its customers include hospitals, pharmacies, and individual consumers across India. The company operates in the broader Indian pharmaceuticals and nutraceuticals market, which has been growing steadily as more people focus on preventive health. The company earns money primarily by manufacturing and selling its products to distributors and retailers, who then sell them to end customers. Deccan Health Care operates mainly within India, and with a market cap of roughly $0.3 billion, it is a small player in a highly competitive industry dominated by much larger domestic and multinational pharmaceutical companies. Its thin operating margin of around 4.4% and low return on invested capital highlight the key risk: the company must improve profitability and scale to stay competitive as larger rivals with stronger distribution networks and bigger research budgets continue to expand in the same market.
Winston Score: 44/100 — Average
Mixed quality — meaningful strengths and weaknesses.
- Quality: Weak (7/30)
- Growth: Good (10/20)
- Cash Flow: Weak (1/10)
- Stability: Exceptional (9/10)
- Valuation: Good (5/10)
- Ownership: Good (10/15)
Key Facts
Price: 13.48 INR
Market Cap: 334M INR
Sector: Healthcare
Industry: Medical - Pharmaceuticals
Exchange: Bombay Stock Exchange


